Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ

DCIS is a molecularly highly heterogenous disease with variable outcomes, and the molecular events determining DCIS disease progression remain poorly defined. Our genome-wide multi-omic survey documents DCIS-associated alterations and reveals molecular heterogeneity within the intrinsic DCIS subtypes. Further studies investigating intrinsic subtype-stratified characteristics and molecular signatures are needed to determine if these may be exploitable for risk assessment and mitigation of DCIS progression. The highly significant associations of specific gene sets with IBC progression revealed by our Gene Set Enrichment Analysis may lend themselves to the development of a prognostic molecular score, to be validated on independent DCIS cohorts.

Authors

Institutions

Publication Details

Journal
Breast Cancer Research
Published
2024-12-04
DOI
https://doi.org/10.1186/s13058-024-01927-1
Citations
4
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
1.14

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ

Katherine A. Hoadley, Leslie Cope, Michael Considine, Brenda Y. Hernandez et al.
4 citations
Breast Cancer Research
Cancer Genomics and Diagnostics
1.14
article

Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ

Katherine A. Hoadley, Leslie Cope, Michael Considine, Brenda Y. Hernandez, P. J. van Diest, Wendy Cozen, Soonweng Cho, Ashley Cimino‐Mathews, Yongchun Wang, Brittany Avin-McKelvey, Christopher B. Umbricht, Liliana Florea, Marija Debeljak, William E. Grizzle, Phillip N. Perez, Debra Hawes, Charles F. Lynch, Bradley M. Downs, Ann S. Hamilton, Edward Gabrielson
article en
4 citations

Abstract

DCIS is a molecularly highly heterogenous disease with variable outcomes, and the molecular events determining DCIS disease progression remain poorly defined. Our genome-wide multi-omic survey documents DCIS-associated alterations and reveals molecular heterogeneity within the intrinsic DCIS subtypes. Further studies investigating intrinsic subtype-stratified characteristics and molecular signatures are needed to determine if these may be exploitable for risk assessment and mitigation of DCIS progression. The highly significant associations of specific gene sets with IBC progression revealed by our Gene Set Enrichment Analysis may lend themselves to the development of a prognostic molecular score, to be validated on independent DCIS cohorts.

Breast Cancer ResearchVol. 26(1)
University of North Carolina at Chapel Hill (US), University of Southern California (US), University of Hawaiʻi at Mānoa (US), University of Iowa (US), University of Hawaii System (US), Children's Hospital of Los Angeles (US), Johns Hopkins University (US), Johns Hopkins Medicine (US), University Medical Center Utrecht (NL), University of Alabama at Birmingham (US), Cancer Research Center (US), University of Baltimore (US)
National Institutes of Health, Holden Comprehensive Cancer Center, University of Iowa, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 20%
Cancer Genomics and Diagnostics
1.14
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.